Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
For effective care of the complicated condition “Congenital Adrenal Hyperplasia (CAH)”, a multidisciplinary approach is necessary. Because it frequently exhibits vague symptoms and can be confused with other disorders, CAH can be difficult to diagnose. A genetic flaw in CAH's etiology causes an excess of androgens to be produced, which can masculinize female embryos and cause early virilization in men. Glucocorticoid treatment and salt supplements are two efficient management techniques for CAH that can help lower androgen levels and prevent salt-wasting crises. For CAH to be successfully managed, close monitoring and follow-up are essential since potential complications and adherence to therapy can have an impact on long-term outcomes. This review article underlines the significance of a thorough strategy that takes into account each patient's unique demands while providing an up-to-date overview of the current therapeutic techniques for newborns with CAH. This article seeks to educate and direct clinicians and researchers in their endeavors to enhance the care and outcomes of infants with CAH by summarizing the most recent research in the area.